The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Neurovestibular Sequelae of Long COVID: A Multisystem Analysis of Vertigo, Genomic Resonance, and Clinical Consequence

Author: John Murphy, MD CEO & President, COVID-19 Long-haul Foundation Abstract Vertigo and disequilibrium are increasingly recognized as disabling sequelae of Long COVID, yet remain under-characterized in clinical literature. This […]

Neuroinflammatory and Glutamatergic Dysregulation in Long COVID: Treating Brain Fog, Confusion, and Depression

John Murphy, – President, COVID-19 Long-haul Foundation Pathophysiology of Long COVID Neurocognitive Sequelae Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is increasingly recognized as a chronic, multisystemic condition […]

Persistent Shadows: Depression, Long COVID, and the Future of Mental Health Care

Author: John Murphy Affiliation: COVID-19 Long-haul Foundation Abstract Long COVID has emerged as a multifaceted syndrome with profound neuropsychiatric consequences. Among its most persistent and disabling sequelae is depression, which […]

Long COVID and brain inflammation: unravelling mechanisms and potential therapies

Fatemeh Saheb Sharif-Askari1,2*†Jacob Raber3*†Karem H. Alzoubi1,2 Patients with Long COVID often experience persistent brain-related symptoms, including brain fog, mood changes, and dizziness (1–3), likely driven by neuroinflammation even after the […]

What do we know about covid-19’s effects on the brain?

BMJ 2024; 385 doi: https://doi.org/10.1136/bmj.q897 (Published 15 May 2024)Cite this as: BMJ 2024;385:q897 What are the neurological symptoms of covid-19? Covid may be primarily a respiratory infection, but a common symptom is “brain fog”—problems with memory or […]

Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use?

Dominique Comeau1† Mykella Martin2† Gilles A. Robichaud3,4,5 Ludivine Chamard-Witkowski2,6*1Dr. Georges-L. Long COVID syndrome, also known as post-acute sequelae of COVID-19 (PASC), is characterized by persistent symptoms lasting 3–12 weeks post SARS-CoV-2 infection. Patients suffering […]